rs1799817

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000208.4(INSR):​c.3255C>T​(p.His1085His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 1,613,618 control chromosomes in the GnomAD database, including 34,069 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3547 hom., cov: 30)
Exomes 𝑓: 0.20 ( 30522 hom. )

Consequence

INSR
NM_000208.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.971

Publications

85 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 19-7125286-G-A is Benign according to our data. Variant chr19-7125286-G-A is described in ClinVar as Benign. ClinVar VariationId is 194701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.971 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.387 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INSRNM_000208.4 linkc.3255C>T p.His1085His synonymous_variant Exon 17 of 22 ENST00000302850.10 NP_000199.2
INSRNM_001079817.3 linkc.3219C>T p.His1073His synonymous_variant Exon 16 of 21 NP_001073285.1
INSRXM_011527988.3 linkc.3252C>T p.His1084His synonymous_variant Exon 17 of 22 XP_011526290.2
INSRXM_011527989.4 linkc.3216C>T p.His1072His synonymous_variant Exon 16 of 21 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkc.3255C>T p.His1085His synonymous_variant Exon 17 of 22 1 NM_000208.4 ENSP00000303830.4
INSRENST00000341500.9 linkc.3219C>T p.His1073His synonymous_variant Exon 16 of 21 1 ENSP00000342838.4
INSRENST00000593970.1 linkn.101C>T non_coding_transcript_exon_variant Exon 1 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31790
AN:
151870
Hom.:
3538
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.229
Gnomad AMI
AF:
0.114
Gnomad AMR
AF:
0.227
Gnomad ASJ
AF:
0.157
Gnomad EAS
AF:
0.401
Gnomad SAS
AF:
0.324
Gnomad FIN
AF:
0.183
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.179
Gnomad OTH
AF:
0.203
GnomAD2 exomes
AF:
0.227
AC:
56640
AN:
249496
AF XY:
0.228
show subpopulations
Gnomad AFR exome
AF:
0.230
Gnomad AMR exome
AF:
0.246
Gnomad ASJ exome
AF:
0.153
Gnomad EAS exome
AF:
0.428
Gnomad FIN exome
AF:
0.178
Gnomad NFE exome
AF:
0.182
Gnomad OTH exome
AF:
0.208
GnomAD4 exome
AF:
0.199
AC:
290172
AN:
1461630
Hom.:
30522
Cov.:
35
AF XY:
0.202
AC XY:
146547
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.227
AC:
7595
AN:
33476
American (AMR)
AF:
0.252
AC:
11250
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.149
AC:
3885
AN:
26136
East Asian (EAS)
AF:
0.369
AC:
14654
AN:
39696
South Asian (SAS)
AF:
0.313
AC:
26954
AN:
86252
European-Finnish (FIN)
AF:
0.184
AC:
9790
AN:
53274
Middle Eastern (MID)
AF:
0.227
AC:
1308
AN:
5752
European-Non Finnish (NFE)
AF:
0.182
AC:
201824
AN:
1111938
Other (OTH)
AF:
0.214
AC:
12912
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
14919
29838
44756
59675
74594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7396
14792
22188
29584
36980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.209
AC:
31836
AN:
151988
Hom.:
3547
Cov.:
30
AF XY:
0.212
AC XY:
15718
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.229
AC:
9487
AN:
41446
American (AMR)
AF:
0.227
AC:
3472
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
545
AN:
3466
East Asian (EAS)
AF:
0.402
AC:
2062
AN:
5134
South Asian (SAS)
AF:
0.323
AC:
1555
AN:
4812
European-Finnish (FIN)
AF:
0.183
AC:
1939
AN:
10582
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.179
AC:
12158
AN:
67970
Other (OTH)
AF:
0.206
AC:
434
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1278
2556
3834
5112
6390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
348
696
1044
1392
1740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.193
Hom.:
11993
Bravo
AF:
0.214
Asia WGS
AF:
0.352
AC:
1222
AN:
3478
EpiCase
AF:
0.180
EpiControl
AF:
0.185

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19211708, 19926323, 22775283) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 14, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
May 08, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Insulin-resistant diabetes mellitus AND acanthosis nigricans Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Rabson-Mendenhall syndrome Benign:1
Jan 15, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Leprechaunism syndrome Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.34
DANN
Benign
0.44
PhyloP100
-0.97
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799817; hg19: chr19-7125297; COSMIC: COSV57158382; COSMIC: COSV57158382; API